171 related articles for article (PubMed ID: 32410863)
41. The macrophage migration inhibitory factor -173G/C polymorphism is not significantly associated with necrotizing enterocolitis in preterm infants.
Prencipe G; Auriti C; Inglese R; Gallusi G; Dotta A; De Benedetti F
J Pediatr Surg; 2013 Jul; 48(7):1499-502. PubMed ID: 23895962
[TBL] [Abstract][Full Text] [Related]
42. Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease.
Dambacher J; Staudinger T; Seiderer J; Sisic Z; Schnitzler F; Pfennig S; Hofbauer K; Konrad A; Tillack C; Otte JM; Diebold J; Göke B; Ochsenkühn T; Lohse P; Brand S
Inflamm Bowel Dis; 2007 Jan; 13(1):71-82. PubMed ID: 17206642
[TBL] [Abstract][Full Text] [Related]
43. Haplotypes of [-794(CATT)
Guevara-Gutiérrez E; Ramos-Súarez M; Villalobos-Ayala RA; Tlacuilo-Parra A; Muñoz-Valle JF; Tarango-Martínez V; Valle Y; Padilla-Gutiérrez JR; Rojas-Díaz JM; Valdés-Alvarado E
Mol Genet Genomic Med; 2023 Nov; 11(11):e2252. PubMed ID: 37485818
[TBL] [Abstract][Full Text] [Related]
44. Increased serum levels and promoter polymorphisms of macrophage migration inhibitory factor in schizophrenia.
Okazaki S; Hishimoto A; Otsuka I; Watanabe Y; Numata S; Boku S; Shimmyo N; Kinoshita M; Inoue E; Ohmori T; Someya T; Sora I
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():33-41. PubMed ID: 29305329
[TBL] [Abstract][Full Text] [Related]
45. Macrophage migration inhibitory factor, Toll-like receptor 4, and CD14 polymorphisms with altered expression levels in patients with ulcerative colitis.
Sivaram G; Tiwari SK; Bardia A; Anjum F; Vishnupriya S; Habeeb A; Khan AA
Hum Immunol; 2012 Feb; 73(2):201-5. PubMed ID: 22192785
[TBL] [Abstract][Full Text] [Related]
46. Macrophage migration inhibitory factor gene: influence on rheumatoid arthritis susceptibility.
Martínez A; Orozco G; Varadé J; Sánchez López M; Pascual D; Balsa A; García A; de la Concha EG; Fernández-Gutiérrez B; Martín J; Urcelay E
Hum Immunol; 2007 Sep; 68(9):744-7. PubMed ID: 17869648
[TBL] [Abstract][Full Text] [Related]
47. The association between the functional PTPN22 1858 C/T and MIF -173 C/G polymorphisms and juvenile idiopathic arthritis: a meta-analysis.
Lee YH; Bae SC; Song GG
Inflamm Res; 2012 May; 61(5):411-5. PubMed ID: 22327470
[TBL] [Abstract][Full Text] [Related]
48. Association of β2-adrenergic receptor gene polymorphisms (rs1042713, rs1042714, rs1042711) with asthma risk: a systematic review and updated meta-analysis.
Zhao S; Zhang W; Nie X
BMC Pulm Med; 2019 Nov; 19(1):202. PubMed ID: 31699066
[TBL] [Abstract][Full Text] [Related]
49. Investigating disease susceptibility and the negative correlation of schizophrenia and rheumatoid arthritis focusing on MIF and CD14 gene polymorphisms.
de la Fontaine L; Schwarz MJ; Riedel M; Dehning S; Douhet A; Spellmann I; Kleindienst N; Zill P; Plischke H; Gruber R; Müller N
Psychiatry Res; 2006 Sep; 144(1):39-47. PubMed ID: 16916546
[TBL] [Abstract][Full Text] [Related]
50. Circulating macrophage migration inhibitory factor levels and its polymorphisms in systemic lupus erythematosus: A meta-analysis.
Bae SC; Lee YH
Cell Mol Biol (Noisy-le-grand); 2017 Oct; 63(10):74-79. PubMed ID: 29096759
[TBL] [Abstract][Full Text] [Related]
51. Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain.
Palomino-Morales R; Gonzalez-Juanatey C; Vazquez-Rodriguez TR; Torres O; Miranda-Filloy JA; Llorca J; Martin J; Gonzalez-Gay MA
Clin Exp Rheumatol; 2010; 28(1):68-72. PubMed ID: 20346241
[TBL] [Abstract][Full Text] [Related]
52. Association of the genetic variants (-794 CATT5-8 and -173 G > C) of macrophage migration inhibitory factor (MIF) with higher soluble levels of MIF and TNFα in women with breast cancer.
Avalos-Navarro G; Del Toro-Arreola A; Daneri-Navarro A; Quintero-Ramos A; Bautista-Herrera LA; Franco Topete RA; Anaya Macias BU; Javalera Castro DI; Morán-Mendoza AJ; Oceguera-Villanueva A; Topete-Camacho A; Muñoz-Valle JF
J Clin Lab Anal; 2020 May; 34(5):e23209. PubMed ID: 31978276
[TBL] [Abstract][Full Text] [Related]
53. Macrophage migration inhibitory factor promoter 173G/C polymorphism is associated with atopic dermatitis risk.
Ma L; Xue HB; Guan XH; Qi RQ; Liu YB
Int J Dermatol; 2014 Jan; 53(1):e75-7. PubMed ID: 23556458
[No Abstract] [Full Text] [Related]
54. Association of endothelial nitric oxide synthase gene polymorphism with the risk of Henoch-Schönlein purpura/Henoch-Schönlein purpura nephritis.
Zhong W; Zhou TB; Jiang Z
Ren Fail; 2015 Apr; 37(3):372-6. PubMed ID: 25585947
[TBL] [Abstract][Full Text] [Related]
55. The macrophage migration inhibitory factor (MIF) gene polymorphism in Czech and Russian patients with myocardial infarction.
Tereshchenko IP; Petrkova J; Mrazek F; Lukl J; Maksimov VN; Romaschenko AG; Voevoda MI; Petrek M
Clin Chim Acta; 2009 Apr; 402(1-2):199-202. PubMed ID: 19167373
[TBL] [Abstract][Full Text] [Related]
56. Oxidative stress-mediated (sex-specific) loss of protection against type-2 diabetes by macrophage migration inhibitory factor (MIF)-173G/C polymorphism.
Coban N; Onat A; Yildirim O; Can G; Erginel-Unaltuna N
Clin Chim Acta; 2015 Jan; 438():1-6. PubMed ID: 25108206
[TBL] [Abstract][Full Text] [Related]
57. Association of MIF promoter polymorphisms with psoriasis in a Han population in northeastern China.
Wu J; Chen F; Zhang X; Li Y; Ma H; Zhou Y; Jin Y; Wang H; Bai J; Zhang G; Fu S
J Dermatol Sci; 2009 Mar; 53(3):212-5. PubMed ID: 19157791
[TBL] [Abstract][Full Text] [Related]
58. Macrophage migration inhibitory factor gene polymorphisms as exacerbating factors of apical periodontitis.
Freer-Rojas A; Martínez-Garibay LC; Torres-Méndez F; Dávila-Pérez CE; Martínez-Castañón GA; Patiño-Marín N; Alegría-Torres JA
Adv Clin Exp Med; 2020 May; 29(5):597-602. PubMed ID: 32427427
[TBL] [Abstract][Full Text] [Related]
59. Haplotypes of (-794(CATT)
Guevara-Gutiérrez E; Castro-Jonguitud MJ; De la Torre-Flores SE; Muñoz-Valle JF; Tlacuilo-Parra A; Salazar-Torres FJ; Valle Y; Padilla-Gutiérrez JR; Martínez-Fernández DE; Valdés-Alvarado E
J Investig Med; 2021 Jan; 69(1):41-46. PubMed ID: 33046523
[TBL] [Abstract][Full Text] [Related]
60. MIF -173G/C polymorphism is associated with NMO disease severity.
Brill L; Vaknin-Dembinsky A; Zveik O; Haham N; Miller K; Benedek G
J Neuroimmunol; 2020 Feb; 339():577120. PubMed ID: 31790982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
